|
WO2014093655A2
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains
|
|
EP3080259B1
(en)
|
2013-12-12 |
2023-02-01 |
The Broad Institute, Inc. |
Engineering of systems, methods and optimized guide compositions with new architectures for sequence manipulation
|
|
US10648020B2
(en)
|
2015-06-18 |
2020-05-12 |
The Broad Institute, Inc. |
CRISPR enzymes and systems
|
|
WO2016205749A1
(en)
|
2015-06-18 |
2016-12-22 |
The Broad Institute Inc. |
Novel crispr enzymes and systems
|
|
US9790490B2
(en)
|
2015-06-18 |
2017-10-17 |
The Broad Institute Inc. |
CRISPR enzymes and systems
|
|
EP4485466A3
(en)
|
2016-08-17 |
2025-04-02 |
The Broad Institute Inc. |
Novel crispr enzymes and systems
|
|
US11970719B2
(en)
*
|
2017-11-01 |
2024-04-30 |
The Regents Of The University Of California |
Class 2 CRISPR/Cas compositions and methods of use
|
|
AU2018358051B2
(en)
|
2017-11-01 |
2025-01-09 |
The Regents Of The University Of California |
CasZ compositions and methods of use
|
|
AU2018370588B2
(en)
|
2017-11-21 |
2022-09-08 |
Genkore Co. Ltd. |
Composition for Genome Editing Using Crispr/CPF1 System and Use Thereof
|
|
KR102929494B1
(ko)
|
2018-10-29 |
2026-02-20 |
차이나 어그리컬처럴 유니버시티 |
신규 CRISPR/Cas12f 효소 및 시스템
|
|
US12258594B2
(en)
|
2018-12-05 |
2025-03-25 |
The Broad Institute, Inc. |
Cas proteins with reduced immunogenicity and methods of screening thereof
|
|
WO2020123887A2
(en)
*
|
2018-12-14 |
2020-06-18 |
Pioneer Hi-Bred International, Inc. |
Novel crispr-cas systems for genome editing
|
|
MX2021010559A
(es)
*
|
2019-03-07 |
2021-12-15 |
Univ California |
Polipéptidos efectores de crispr-cas y métodos de uso de estos.
|
|
WO2020223634A1
(en)
|
2019-05-01 |
2020-11-05 |
Mammoth Biosciences, Inc. |
Programmable nucleases and methods of use
|
|
EP3772329A1
(fr)
*
|
2019-08-08 |
2021-02-10 |
PKvitality |
Systeme de surveillance corporelle comprenant une microaiguille
|
|
WO2021084533A1
(en)
*
|
2019-10-28 |
2021-05-06 |
Targetgene Biotechnologies Ltd |
Pam-reduced and pam-abolished cas derivatives compositions and uses thereof in genetic modulation
|
|
CN114846146B
(zh)
|
2019-10-29 |
2024-04-12 |
基恩科雷有限责任公司 |
用于增加CRISPR/Cas12f1系统的效率的工程化引导RNA及其用途
|
|
CA3192654A1
(en)
*
|
2020-09-01 |
2022-03-10 |
The Board Of Trustees Of The Leland Stanford Junior Unversity |
Synthetic miniature crispr-cas (casmini) system for eukaryotic genome engineering
|
|
CN116568803A
(zh)
|
2020-10-08 |
2023-08-08 |
基恩科雷有限责任公司 |
用于增加CRISPR/Cas12f1系统的效率的包含富含U的尾部的经工程化的引导RNA及其用途
|
|
CA3198435A1
(en)
|
2020-10-08 |
2022-04-14 |
Genkore Inc. |
Engineered guide rna for optimized crispr/cas12f1 (cas14a1) system and use thereof
|
|
EP4227411A4
(en)
|
2020-10-08 |
2025-07-09 |
Genkore Inc |
MODIFIED GUIDE RNA TO INCREASE THE EFFICIENCY OF THE CRISPR/CAS12F1 SYSTEM, AND ITS USE
|
|
EP4267252A4
(en)
|
2020-12-23 |
2025-07-23 |
Mammoth Biosciences Inc |
COMPOSITIONS AND METHODS OF USING PROGRAMMABLE NUCLEASES TO INDUCE CELL DEATH
|
|
WO2022150372A1
(en)
|
2021-01-05 |
2022-07-14 |
Horizon Discovery Ltd. |
Guide rna designs and complexes for type v cas systems
|
|
WO2022266324A1
(en)
|
2021-06-17 |
2022-12-22 |
Epicrispr Biotechnologies, Inc. |
Systems and methods for regulating aberrant gene expressions
|
|
KR20230007218A
(ko)
*
|
2021-07-05 |
2023-01-12 |
주식회사 진코어 |
초소형 염기교정 시스템 및 이의 용도
|
|
IL310116A
(en)
|
2021-07-20 |
2024-03-01 |
Epicrispr Biotechnologies Inc |
Systems and methods for regulating target genes
|
|
US20240252684A1
(en)
|
2021-07-30 |
2024-08-01 |
Tune Therapeutics, Inc. |
Compositions and methods for modulating expression of methyl-cpg binding protein 2 (mecp2)
|
|
CN119137268A
(zh)
|
2022-03-01 |
2024-12-13 |
埃皮克里斯皮尔生物技术公司 |
工程化核酸酶、组合物及其使用方法
|
|
WO2023172995A1
(en)
|
2022-03-11 |
2023-09-14 |
Epicrispr Biotechnologies, Inc. |
Systems and methods for genetic modulation to treat ocular diseases
|
|
WO2023173072A1
(en)
|
2022-03-11 |
2023-09-14 |
Epicrispr Biotechnologies, Inc. |
Systems and methods for genetic modulation to treat liver disease
|
|
EP4490295A4
(en)
|
2022-03-11 |
2026-03-18 |
Epicrispr Biotechnologies Inc |
GENETIC MODULATION SYSTEMS AND METHODS FOR TREATING EYE DISEASES
|
|
WO2023173110A1
(en)
|
2022-03-11 |
2023-09-14 |
Epicrispr Biotechnologies, Inc. |
Compositions, systems, and methods for treating familial hypercholesterolemia by targeting pcsk9
|
|
CA3253453A1
(en)
|
2022-03-24 |
2023-09-28 |
Epicrispr Biotechnologies, Inc. |
MODIFIED GENE EFFECTORS, COMPOSITIONS AND THEIR METHODS OF USE
|